A signal peptide missense mutation associated with nicotine dependence alters α2*-nicotinic acetylcholine receptor function

Neuropharmacology. 2014 Apr:79:715-25. doi: 10.1016/j.neuropharm.2014.01.021. Epub 2014 Jan 24.

Abstract

A cytosine to thymidine (C → T) missense mutation in the signal peptide (SP) sequence (rs2472553) of the nicotinic acetylcholine receptor (nAChR) α2 subunit produces a threonine-to-isoleucine substitution (T22I) often associated with nicotine dependence (ND). We assessed effects on function of α2*-nAChR ('*'indicates presence of additional subunits) of this mutation, which could alter SP cleavage, RNA/protein secondary structure, and/or efficiency of transcription, translation, subunit assembly, receptor trafficking or cell surface expression. Two-electrode voltage clamp analyses indicate peak current responses to ACh or nicotine are decreased 2.8-5.8-fold for putative low sensitivity (LS; 10:1 ratio of α:β subunit cRNAs injected) α2β2- or α2β4-nAChR and increased for putative high sensitivity (HS; 1:10 α:β subunit ratio) α2β2- (5.7-15-fold) or α2β4- (1.9-2.2-fold) nAChR as a result of the mutation. Agonist potencies are decreased 1.6-4-fold for putative LS or HS α2(T22I)β2-nAChR or for either α2*-nAChR subtype formed in the presence of equal amounts of subunit cRNA, slightly decreased for LS α2(T22I)β4-nAChR, but increased 1.4-2.4-fold for HS α2(T22I)β4-nAChR relative to receptors containing wild-type α2 subunits. These effects suggest that the α2 subunit SP mutation generally favors formation of LS receptor isoforms. We hypothesize that lower sensitivity of human α2*-nAChR to nicotine could contribute to increased susceptibility to ND. To our knowledge this is the first report of a SP mutation having a functional effect in a member of cys-loop family of ligand-gated ion channels.

Keywords: Electrophysiology; Missense mutation; Nicotinic acetylcholine receptor; Receptor structure-function; Signal peptide; Single nucleotide polymorphism.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetylcholine / metabolism
  • Amino Acid Sequence
  • Animals
  • Genetic Predisposition to Disease
  • Humans
  • Mecamylamine / pharmacology
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Mutation, Missense*
  • Nerve Tissue Proteins / metabolism
  • Nicotine / pharmacology
  • Nicotinic Agonists / pharmacology
  • Nicotinic Antagonists / pharmacology
  • Patch-Clamp Techniques
  • Polymorphism, Single Nucleotide
  • Receptors, Nicotinic / genetics*
  • Receptors, Nicotinic / metabolism*
  • Species Specificity
  • Tobacco Use Disorder / genetics*
  • Xenopus laevis

Substances

  • CHRNA2 protein, human
  • CHRNB4 protein, human
  • Nerve Tissue Proteins
  • Nicotinic Agonists
  • Nicotinic Antagonists
  • Receptors, Nicotinic
  • nicotinic receptor beta2
  • Mecamylamine
  • Nicotine
  • Acetylcholine